Supernus Pharmaceuticals, Inc. - Common Stock - fluxo de caixa trimestral (NASDAQ:SUPN) | MetaTrader

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Fluxo de caixa operacional 44.41 M30.6 M58.53 M-61.66 M19.86 M66.52 M 83.26 M Fluxo de caixa de investimento -12.64 M37.32 M-30.61 M48.71 M-51.31 M-19.22 M -52.43 M Fluxo de caixa de financiamento 5.89 M-21.4 M935 K21.07 M8.53 M9.12 M 39.64 M Fluxo de caixa livre 44.41 M30.6 M58.08 M-61.79 M19.43 M66.52 M 82.25 M

Notícias

Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right (NASDAQ:XERS)

Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD?

Supernus Pharmaceuticals pagará US$ 33,4 milhões em marco de CVR

Supernus Pharmaceuticals, Inc. (SUPN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Supernus Pharmaceuticals, Inc. (SUPN) Q1 2026 Earnings Call Transcript

Supernus (SUPN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates

Bausch Health (BHC) Lags Q1 Earnings Estimates

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs

Biogen Walloped Wall Street's First Quarter Views; Here's What Happened

BofA reduz preço-alvo da Supernus Pharmaceuticals devido a custos

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?